# VDA Pharma, Inc. — Form D

VDA Pharma, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-24. The offering totals $80K, of which $55K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-09-24
- Form: D
- Accession: 0001654001-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $80K
- Amount sold: $55K
- Remaining: $25K
- Minimum investment: $5K
- Investors: 4
- Date of first sale: 2015-08-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-248202

## Issuer

- Name: VDA Pharma, Inc.
- CIK: 0001654001
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 500 UNION STREET, SEATTLE, WA, 98101
- Phone: 206-682-1181

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Donald James Elmer | Director | Seattle, WA |

## More

- [CIK 1654001 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1654001&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001654001-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.